- Home
- Clinical Trials
Atrial Fibrillation Study Brisbane WH 70
Atrial Fibrillation Study
Wellers Hill Brisbane
Please note that this study has now closed. However, we encourage you to pre-register your interest for future atrial fibrillation studies here.
Description
What to expect
Study details
Ages
18+ years old
Duration
A minimum duration of 3 months, with an expected duration of 2 years.
Compensation
Eligible participants will be compensated for time and travel-related costs.
Eligibility Criteria
You may be eligible to take part if you:
- Are 18 years of age or older AND
- Suffer from Atrial Fibrillation
Locations
Description
Blood thinners remain a cornerstone in the treatment for Atrial Fibrillation.
Atrial fibrillation (also knowns as AFib), is a common type of cardiac arrhythmia, which refers to an irregular heartbeat rhythm. As a result, the heart cannot pump blood effectively which can lead to a variety of symptoms, including palpitations, shortness of breath, and fatigue.
Without management, Atrial Fibrillation can lead to formation of blood clots, increasing the risk of stroke, heart failure, and other heart-related complications. Many blood-thinner therapies are currently available, but the disadvantage is that they can increase the risk of bleeding.
What to expect
Momentum is conducting a study evaluating the effectiveness of a new blood thinner treatment intended to stop the formation of blood clots in people with atrial fibrillation, with a significantly reduced risk of bleeding.
The study has a minimum duration of 3 months, with an expected duration of 2 years.
Eligible participants will be compensated for time and travel-related costs.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future atrial fibrillation studies here.